Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors

Journal of General Virology

Volumn 78, Issue 7, 1997, Pages 1653-1660

  Addison, Christina L ^a   Hitt, Mary ^a   Kunsken, Derek ^a   Graham, Frank L ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GENE PRODUCT; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMEDIATE EARLY GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE;

ADENOVIRIDAE; ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5; MAIZE CHLOROTIC MOTTLE VIRUS; MOUSE CYTOMEGALOVIRUS 1; MURINAE;

EID: 0030860068     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-7-1653     Document Type: Article

References (39)

1. Addison, C. L., Braciak, T., Ralston, R., Muller, W. J., Gauldie, J. & Graham, F. L. (1995 a). Intra-tumoral injection of an adenovirus expressing interleukin-2 induces regression and immunity in a murine breast cancer model. Proceedings of the National Academy of Sciences, USA 92, 8522-8526.
2. Addison, C. L., Gauldie, J., Muller, W. J. & Graham, F. L. (1995 b). An adenoviral vector expressing interleukin-4 modulates tumorigenicity and induces regression in a murine breast cancer model. International Journal of Oncology 7, 1253-1260.
3. Anton, M. & Graham, F. L. (1995). Site-specific recombination mediated by an adenovirus vector expressing the cre recombinase protein: a molecular switch for control of gene expression. Journal of Virology 69, 4600-4606.
4. Baskar, J. F., Smith, P., Ciment, G. S., Hoffmann, S., Tucker, C., Tenney, D. J., Colberg-Poley, A. M., Nelson, J. A. & Ghazal, P. (1996 a). Developmental analysis of the cytomegalovirus enhancer in transgenic animals. Journal of Virology 70, 3215-3226.
5. Baskar, J. F., Smith, P. P., Nilaver, G., Jupp, R. A., Hoffmann, S., Peffer, N. J., Tenney, D. J., Colberg-Poley, A. M., Ghazal, P. & Nelson, J. A. (1996 b). The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. Journal of Virology 70, 3207-3214.
6. Bett, A. J. (1995). Construction and characterization of recombinant human adenovirus type 5 vectors. PhD thesis, McMaster University, Hamilton, Ontario, Canada.
7. Bett, A. J., Haddara, W., Prevec, L. & Graham, F. L. (1994). An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proceedings of the National Academy of Sciences, USA 91, 8802-8806.
8. Boshart, M., Weber, F., Jahn, G., Dorsch-Hasler, K., Fleckenstein, B. & Schaffner, W. (1985). A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41, 521-530.
9. Bramson, J., Hitt, M., Addison, C. L., Muller, W. J., Gauldie, J. & Graham, F. L. (1996 a). Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12. Human Gene Therapy 7, 1995-2002.
10. Bramson, J., Hitt, M., Gallichan, W. S., Rosenthal, K. L., Gauldie, J. & Graham, F. L. (1996 b). Construction of a double recombinant adeno-virus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12. Human Gene Therapy 7, 333-342.
11. DeWet, J. R., Wood, K. V., DeLuca, M., Helinski, D. R. & Subramani, S. (1987). Firefly luciferase gene: structure and expression in mammalian cells. Molecular and Cellular Biology 7, 725-737.
12. Dorsch-Hasler, K., Keil, G. M., Weber, F., Jasin, M., Schaffner, W. & Koszinowski, U. H. (1985). A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. Proceedings of the National Academy of Sciences, USA 82, 8325-8329.
13. Engelhardt, J. F., Ye, X., Doranz, B. & Wilson, J. M. (1994). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proceedings of the National Academy of Sciences, USA 91, 6196-6200.
14. Fickenscher, H., Stamminger, T., Ruger, R. & Fleckenstein, B. (1989). The role of repetitive palindromic sequence elements in the human cytomegalovirus immediate early enhancer. Journal of General Virology 70, 107-123.
15. Fidler, I. J. (1975). Biological behaviour of malignant melanoma cells correlated to their survival in vivo. Cancer Research 35, 218-234.
16. Gerard, R. D. & Meidell, R. S. (1995). Adenovirus vectors. In DNA Cloning: A Practical Approach, pp. 285-306. Edited by B. D. Hames & D. Glover. Oxford: Oxford University Press.
17. Ghazal, P., Lubon, H. & Hennighausen, L. (1988). Multiple sequence-specific transcription factors modulate cytomegalovirus enhancer activity in vitro. Molecular and Cellular Biology 8, 1809-1811.
18. Graham, F. L., Smiley, J., Russell, W. C. & Nairn, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. Journal of General Virology 36, 59-72.
19. Guy, C. T., Cardiff, R. D. & Muller, W. J. (1992). Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Molecular and Cellular Biology 12, 954-961.
20. Hennighausen, L. & Fleckenstein, B. (1986). Nuclear factor 1 interacts with five DNA elements in the promoter region of the human cytomegalovirus major immediate early gene. EMBO Journal 5, 1367-1371.
21. Herlyn, M., Thurin, J., Balaban, G., Bennicelli, J. L., Herlyn, D., Elder, D. E., Bondi, E., Guerry, D., Nowell, P., Clark, W. H. & Koprowski, H. (1985). Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Research 45, 5670-5676.
22. Hitt, M., Bett, A. J., Addison, C. L., Prevec, L. & Graham, F. L. (1995). Techniques for human adenovirus vector construction and characterization. Methods in Molecular Genetics 7, 13-30.
23. Hunninghake, G. W., Monick, M. M., Liu, B. & Stinski, M. F. (1989). The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements. Journal of General Virology 63, 3026-3033.
24. Kothary, R., Barton, S. C., Franz, T., Norris, M. L., Hettle, S. & Surani, M. A. H. (1991). Unusual cell specific expression of a major human cytomegalovirus immediate early gene promoter-lacZ hybrid gene in transgenic mouse embryos. Mechanisms of Development 35, 25-31.
25. Kozak, M. (1991). Structural features in eukaryotic mRNAs that modulate the initiation of translation. Journal of Biological Chemistry 266, 19867-19870.
26. Lafemina, R. L. & Hayward, G. S. (1988). Differences in cell type-specific blocks to immediate early gene expression and DNA replication of human, simian, and murine cytomegalovirus. Journal of General Virology 69, 353-374.
27. McGrory, W. J., Bautista, D. & Graham, F. L. (1988). A simple technique for the rescue of early region 1 mutations into infectious human adenovirus type 5. Virology 163, 614-617.
28. Mittal, S. K., McDermott, M. R., Johnson, D. C., Prevec, L. & Graham, F. L. (1993). Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Research 28, 67-90.
29. Nelson, J. A. & Groudine, M. (1986). Transcriptional regulation of the human cytomegalovirus immediate-early gene is associated with induction of DNasel-hypersensitive sites. Molecular and Cellular Biology 6, 452-461.
30. Niller, H. H. & Hennighausen, L. (1991). Formation of several specific nucleoprotein complexes on the human cytomegalovirus immediate early enhancer. Nucleic Acids Research 19, 3715-3721.
31. Parks, R. J., Chen, L., Anton, M., Sankar, U., Rudnicki, M. A. & Graham, F. L. (1996). A helper-dependent adenovirus vector system: removal of helper virus by cre-mediated excision of the viral packaging signal. Proceedings of the National Academy of Sciences, USA 93, 13565-13570.
32. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
33. Sambucetti, L. C., Cherrington, J. M., Wilkinson, G. W. G. & Mocarski, E. S. (1989). NF-κB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO Journal 8, 4251-4258.
34. Schmidt, E. V., Christoph, G., Zeller, R. & Leder, P. (1990). The cytomegalovirus enhancer: a pan-active control element in transgenic mice. Molecular and Cellular Biology 10, 4406-4411.
35. Stamminger, T., Fickenscher, H. & Fleckenstein, B. (1990). Cell-type-specific induction of the major immediate-early enhancer of human cytomegalovirus by cyclic AMP. Journal of General Virology 71, 105-113.
36. Stinski, M. F. (1990). Cytomegalovirus and its replication. In Virology, 2nd edn, pp. 1959-1980. Edited by B. N. Fields & D. M. Knipe. New York: Raven Press.
37. Wilkinson, G. W. G. & Akrigg, A. (1992). Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Research 20, 2233-2239.
38. Xu, Z. Z., Krougliak, V., Prevec, L., Graham, F. L. & Both, G. W. (1995). Investigation of promoter function in human and animal cells infected with human recombinant adenoviruses expressing rotavirus antigen VP7sc. Journal of General Virology 76, 1971-1980.
39. Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gonczol, E. & Wilson, J. M. (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proceedings of the National Academy of Sciences, USA 91, 4407-4411.